Loı̈c Guillevin
Researcher Next ID · RN-032538
Researcher · Medicine
Paris, France
- Works count
- 1,395
- Citation count
- 67,033
- H-index
- 124
- i10-index
- 560
Research interests
Publications
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Carolina Digital Repository (University of North Carolina at Chapel Hill) · 2020 · https://doi.org/10.17615/tnnw-jw94
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1803537
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-12515-9
Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)
Annals of the Rheumatic Diseases · 2018 · https://doi.org/10.1136/annrheumdis-2017-212878
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
The Lancet Infectious Diseases · 2017 · https://doi.org/10.1016/s1473-3099(16)30521-7
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1404231
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.37715
Genetically Distinct Subsets within ANCA-Associated Vasculitis
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1108735
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Arthritis & Rheumatism · 2012 · https://doi.org/10.1002/art.37721
Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
Arthritis & Rheumatism · 2010 · https://doi.org/10.1002/art.27555
The Five-Factor Score Revisited
Medicine · 2010 · https://doi.org/10.1097/md.0b013e318205a4c6
Vasculitides associated with malignancies: Analysis of sixty patients
Arthritis Care & Research · 2007 · https://doi.org/10.1002/art.23085
FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity
Nature Genetics · 2007 · https://doi.org/10.1038/ng2046
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
Journal of the American Society of Nephrology · 2007 · https://doi.org/10.1681/asn.2007010090
Assessing disability and quality of life in systemic sclerosis: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36‐Item Short Form Health Survey
Arthritis Care & Research · 2007 · https://doi.org/10.1002/art.22468
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Annals of Internal Medicine · 2005 · https://doi.org/10.7326/0003-4819-143-9-200511010-00006
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
Arthritis & Rheumatism · 2005 · https://doi.org/10.1002/art.21433
Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonist
Arthritis & Rheumatism · 2004 · https://doi.org/10.1002/art.20676
Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine · 1999 · https://doi.org/10.1097/00005792-199901000-00003
The spectrum of vasculitis in human immunodeficiency virus–infected patients. a clinicopathologic evaluation
Arthritis & Rheumatism · 1993 · https://doi.org/10.1002/art.1780360818
Current projects
No projects listed.